Saki Ito1, Sorin V Pislaru1, Wern Miin Soo2, Runqing Huang1, Kevin L Greason3, Verghese Mathew1, Gurpreet S Sandhu1, Mackram F Eleid1, Rakesh M Suri4, Jae K Oh1, Vuyisile T Nkomo5. 1. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. 2. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; National University Heart Center Singapore, Singapore. 3. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA. 4. Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA. 5. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: nkomo.vuyisile@mayo.edu.
Abstract
BACKGROUND: The impact of pre-procedural RV size and function on outcomes following transcatheter aortic valve replacement (TAVR) is not well established. The aim of this study was to investigate the role of right ventricular size and function on outcomes following TAVR. METHODS AND RESULTS: Between November 2008 and June 2013, 268 consecutive patients (age 80.5±7.9years, aortic valve area 0.79±0.16cm(2)) with symptomatic severe aortic stenosis (AS) undergoing TAVR at Mayo Clinic were included. Transthoracic echocardiographic quantitative and semiquantitative assessment of RV chamber size and systolic function was performed and included tricuspid annular plane systolic excursion (TAPSE), RV systolic excursion velocity (S'), fractional area change (FAC), RV index of myocardial performance (RIMP). The primary endpoint of all-cause mortality after TAVR was measured and observed in 65 patients (median follow up duration: 412days). Univariate analysis identified semiquantitative RV dilatation (p<0.001) and systolic dysfunction (p=0.013), RV basal dimension (p=0.003) and RV outflow proximal dimension (p=0.031) to be of prognostic significance. After multivariate adjustment, patients with semiquantitative RV dilatation (HR 2.61, 95% CI 1.45-4.65, p=0.002) and larger RV basal dimension (HR 1.07, 95% CI per mm 1.02-1.11, p=0.007) had significantly worse survival even after adjusting for age, sex, Society of Thoracic Surgeons (STS) risk score, left ventricular ejection fraction, tricuspid regurgitation, pulmonary artery systolic pressure, and atrial fibrillation. CONCLUSION: RV dilatation is an important determinant of postoperative outcomes in patients undergoing TAVR.
BACKGROUND: The impact of pre-procedural RV size and function on outcomes following transcatheter aortic valve replacement (TAVR) is not well established. The aim of this study was to investigate the role of right ventricular size and function on outcomes following TAVR. METHODS AND RESULTS: Between November 2008 and June 2013, 268 consecutive patients (age 80.5±7.9years, aortic valve area 0.79±0.16cm(2)) with symptomatic severe aortic stenosis (AS) undergoing TAVR at Mayo Clinic were included. Transthoracic echocardiographic quantitative and semiquantitative assessment of RV chamber size and systolic function was performed and included tricuspid annular plane systolic excursion (TAPSE), RV systolic excursion velocity (S'), fractional area change (FAC), RV index of myocardial performance (RIMP). The primary endpoint of all-cause mortality after TAVR was measured and observed in 65 patients (median follow up duration: 412days). Univariate analysis identified semiquantitative RV dilatation (p<0.001) and systolic dysfunction (p=0.013), RV basal dimension (p=0.003) and RV outflow proximal dimension (p=0.031) to be of prognostic significance. After multivariate adjustment, patients with semiquantitative RV dilatation (HR 2.61, 95% CI 1.45-4.65, p=0.002) and larger RV basal dimension (HR 1.07, 95% CI per mm 1.02-1.11, p=0.007) had significantly worse survival even after adjusting for age, sex, Society of Thoracic Surgeons (STS) risk score, left ventricular ejection fraction, tricuspid regurgitation, pulmonary artery systolic pressure, and atrial fibrillation. CONCLUSION: RV dilatation is an important determinant of postoperative outcomes in patients undergoing TAVR.
Authors: Richard G Axell; Joel P Giblett; Paul A White; Andrew Klein; James Hampton-Til; Michael O'Sullivan; Denise Braganza; William R Davies; Nick E J West; Cameron G Densem; Stephen P Hoole Journal: J Am Heart Assoc Date: 2017-06-06 Impact factor: 5.501
Authors: Didrik Kjønås; Gry Dahle; Henrik Schirmer; Siri Malm; Jo Eidet; Lars Aaberge; Terje Steigen; Svend Aakhus; Rolf Busund; Assami Rösner Journal: Open Heart Date: 2019-04-23
Authors: Salih N Grevious; Marcelo F Fernandes; Ama K Annor; Michel Ibrahim; Garly R Saint Croix; Eduardo de Marchena; Mauricio G Cohen; Carlos E Alfonso Journal: J Am Heart Assoc Date: 2020-06-10 Impact factor: 5.501